Clinical Case of Diagnosis and Treatment of Skin Cancer from Sebaceous Glands

Cover Page

Cite item

Full Text

Abstract

Skin cancer from sebaceous glands is a rare and aggressive malignant tumor developing from skin appendages. The etiology of this tumor is still unclear and requires further investigation. Furthermore, strict guidelines on management of patients with this pathology have not been formulated. The article presents a clinical case of diagnosis and treatment of skin cancer from sebaceous glands.

About the authors

K. S. Titov

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department ; Peoples’ Friendship University of Russia

ORCID iD: 0000-0003-4460-9136

5 2nd Botkinskij Proezd, Moscow 125284

6 Miklukho-Maklaya St., Moscow, 117198

Russian Federation

Sh. R. Dzhamilov

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department

Author for correspondence.
Email: 9211824533@mail.ru
ORCID iD: 0000-0002-1445-7277

5 2nd Botkinskij Proezd, Moscow 125284

Russian Federation

I. N. Lebedinsky

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department

ORCID iD: 0000-0001-7735-1106

5 2nd Botkinskij Proezd, Moscow 125284

Russian Federation

P. M. Gur’eva

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department

ORCID iD: 0009-0002-8036-6848

5 2nd Botkinskij Proezd, Moscow 125284

Russian Federation

M. V. Sorokina

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department

ORCID iD: 0000-0002-4436-8101

5 2nd Botkinskij Proezd, Moscow 125284

Russian Federation

E. I. Zakurdaev

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department

ORCID iD: 0000-0001-8613-9609

5 2nd Botkinskij Proezd, Moscow 125284

Russian Federation

D. N. Grekov

S.P. Botkin City Clinical Hospital, Moscow Healthcare Department ; Russian Medical Academy of Continuous Professional Education

ORCID iD: 0000-0001-8391-1210

5 2nd Botkinskij Proezd, Moscow 125284

Bld. 1, 2/1 Barrikadnaya St., Moscow 125993

Russian Federation

References

  1. Kazakov D.V., McKee P.H., Michal M., Kacerovska D. Cutaneous adnexal tumors. 1st edn. Philadelphia: Lippincott Williams and Wilkins Health, 2012.
  2. Owen J.L., Kibbi N., Worley B. et al. Sebaceous carcinoma: evidence-based clinical practice guidelines. Lancet Oncol 2019;20(12):e699–714. doi: 10.1016/S1470-2045(19)30673-4
  3. Gall R., Ortiz-Perez S. Sebaceous gland carcinoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK562223/.
  4. Ouyang Y.-H. Skin cancer of the head and neck. Semin Plastic Surg 2010;24(2):117–26. doi: 10.1055/s-0030-1255329. ISSN 1535-2188
  5. Knackstedt T., Samie F.H. Sebaceous carcinoma: a review of the scientific literature. Curr Treat Options Oncol 2017;18(8):47. doi: 10.1007/s11864-017-0490-0
  6. Ishida M., Iwai M., Yoshida K. et al. Sebaceous carcinoma associated with Bowen’s disease: a case report with emphasis on the pathogenesis of sebaceous carcinoma. Int J Clin Exp Pathol 2013;6(12):3029–32.
  7. Wu A., Rajak S.N., Huilgol Sh.C. et al. Cutaneous sebaceous carcinoma. Australas J Dermatol 2020;61(3):e283–92. doi: 10.1111/ajd.13234
  8. Kyllo R.L., Brady K.L., Hurst E.A. Sebaceous carcinoma: review of the literature. Dermatol Surg 2015;41(1):1–15. doi: 10.1097/DSS.0000000000000152
  9. Flux K. Sebaceous Neoplasms. Surg Pathol Clin 2017;10(2):367–82. doi: 10.1016/j.path.2017.01.009
  10. Takeda H., Lyle S., Lazar A.J. et al. Human sebaceous tumors harbor inactivating mutations in LEF1. Nat Med 2006;12(4):395–7. doi: 10.1038/nm1386
  11. Gay J.T., Troxell T., Gross G.P. Muir-torre syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2023.
  12. Jessup C.J., Redston M., Tilton E., Reimann J.D. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir–Torre syndrome. Hum Pathol 2016;49:1–9. doi: 10.1016/j.humpath.2015.10.005
  13. Tetzlaff M.T., Singh R.R., Seviour E.G. et al. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma. J Pathol 2016;240(1):84–95. doi: 10.1002/path.4759
  14. Lee M.J., Kim N., Choung H.K. et al. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target. J Cancer Res Clin Oncol 2016;142(1):125–33. doi: 10.1007/s00432-015-2009-z
  15. Sargen M.R., Starrett G.J., Engels E.A. et al. Sebaceous carcinoma epidemiology and genetics: emerging concepts and clinical implications for screening, prevention, and treatment. Clin Cancer Res 2021;27(2):389–93. doi: 10.1158/1078-0432.ccr-20-2473
  16. Sekgololo J.M., Chauke R.F., Tshazi N. A rare giant extraocular, anterior chest wall sebaceous carcinoma. Int J Surg Case Rep 2020;66:110–4. doi: 10.1016/j.ijscr.2019.11.054
  17. Dermatooncology. Ed. by G.A. Galil-ogly, V.A. Molochkov, Yu.V. Sergeeva. Moscow, 2005. 443 p. (In Russ.).
  18. Sebaceous tumors. Atlas of mohs and frozen section cutaneous pathology. Ed. by M.B. Morgan, J.R. Hamill, J.M. Spencer. NY: Springer, 2010. Pp. 133–140.
  19. Roberts M.E., Riegert-Johnson D.L., Thomas B.C. et al. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir–Torre variant of Lynch syndrome. Genet Med 2014;16(9):711–6. doi: 10.1038/gim.2014.19
  20. John A.M., Schwartz R.A. Muir–Torre syndrome (MTS): an update and approach to diagnosis and management. J Am Acad Dermatol 2016;74(3):558–66. doi: 10.1016/j.jaad.2015.09.074
  21. Dany M. The DNA mismatch repair system in sebaceous tumors: an update on the genetics and workup of Muir-Torre syndrome. Cutis 2020;105(3):E34–7.
  22. Dasgupta T., Wilson L.D., Yu J.B. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer 2009;115(1):158–65. doi: 10.1002/cncr.23952

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Titov K.S., Dzhamilov S.R., Lebedinsky I.N., Gur’eva P.M., Sorokina M.V., Zakurdaev E.I., Grekov D.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-66671 от  09.11.2009.